Impact Factor
3.41
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.50
317 total citations
h5-index
20
h5 depth signal
Cited share
80.0%
80 of 100
Total citations
317
Citation footprint
Metric signal
3.64
External metric anchor
Self-citation
6.0%
19 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
91
Italy
44
China
41
Japan
17
Turkey
10
Citing Fields of Research
Kidney Diseases
329
Cardiology
270
Urology
112
Diabetes
41
Osteopathies
25
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
679
Articles tracked across the journal lifetime
Indexed publication set
100
80 cited publications
Last 12 months
53
5.9 publications/month
Open access share
100.0%
53 OA publications in the last year
Leading citing country
United States
91 citing publications
Leading citing field
Kidney Diseases
329 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v8n1, 2018-
v1n1, Jan. 2011-
Active Coverage
Research Focus & Classification
Indexed Subjects
Kidney Diseases
Cardiology
Diabetes
Broad Categories
Cardiology
Metabolism
Nephrology
Urology
MeSH Descriptors
Heart Diseases
Kidney Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1159/crm/abtag019
Open DOI
High-sensitivity C-Reactive Protein as a Risk-Enhancing Biomarker in Patients with Chronic Kidney Disease and Atherosclerotic Cardiovascular Disease: A Narrative Review
Background: Patients with chronic kidney disease (CKD) have a >10-fold higher risk of cardiovascular mortality than the general population, influenced by both traditional and non-traditional risk factors. Residual cardiovascular risk per...
02
DOI 10.1159/crm/abtag018
Open DOI
Utilities of Sodium-Glucose Cotransporter-2 Inhibitor in the Intensive Care Units
Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have become foundational therapies for heart failure and chronic kidney disease and are increasingly used in critically ill patients. Their established benefits for kidney and...
03
DOI 10.1159/crm/abtag011
Open DOI
Target weight optimization based on a modified VExUS protocol in hemodialysis: the VexHD prospective multi-center study
Introduction. Clinical examination has limitations in estimating fluid overload in hemodialysis patients. The aim of the present study is to evaluate the impact of target weight optimization using a modified Venous Excess Ultrasonography...
04
DOI 10.1159/crm/abtag001
Open DOI
Finerenone in Reducing Proteinuria: Clinical Effects, Underlying Mechanisms, and Associated Cardiorenal Protection
Proteinuria remains a cardinal surrogate of renal injury and cardiorenal risk, However, residual albuminuria is commonly observed after the treatment with renin–angiotensin–aldosterone system (RAAS) blockade or sodium–glucose cotransport...
05
DOI 10.1159/crm/abtag002
Open DOI
Pressure–Strain Loop-Derived Myocardial Work in Hemodialysis versus Peritoneal Dialysis: A Cross-Sectional Echocardiographic Study
Objective Cardiovascular disease remains the leading cause of mortality in patients with end-stage renal disease (ESRD) patients. However, direct comparisons of myocardial performance between hemodialysis (HD) and peritoneal dialysis (PD...
06
DOI 10.1159/crm/abtag015
Open DOI
Right Ventricular Free Wall Strain Is Associated with Low-Grade Albuminuria in HFpEF: A Cross-Sectional Cohort Study
Introduction Heart failure with preserved ejection fraction (HFpEF) presents a major health burden worldwide. Up to 40% of HFpEF patients present with elevated urine-albumin-creatinine-ratio levels (UACR). In this subgroup, the risk for ...
07
DOI 10.1159/crm/abtag014
Open DOI
Individual Venous Doppler Abnormalities and Clinical Outcomes in Acute Heart Failure: Insights Beyond the Global VExUS Score
Background: Systemic venous congestion contributes to organ dysfunction and adverse outcomes in acute heart failure (AHF). The Venous Excess Ultrasound Score (VExUS) evaluates venous congestion, but its prognostic role and the relative c...
08
DOI 10.1159/crm/abtag012
Open DOI
Cardiovascular-Kidney-Metabolic Syndrome: Is the Evidence Keeping Pace with the Concept?
09
DOI 10.1159/crm/abtag007
Open DOI
Liver-Kidney-Heart Axis in MASLD: Molecular and Cellular Pathways of Renal Injury Associated with Metabolic Hepatic Steatosis. A Narrative Review
Background: Steatotic liver disease associated with metabolic dysfunction (MASLD) has become the most common chronic liver disease worldwide. The impact of this condition is not limited to liver dysfunction; its relationship with chronic...
10
DOI 10.1159/crm/abtag010
Open DOI
Comparative efficacy of interventions for vascular calcification and stiffness in dialysis patients:a systematic review and network meta-analysis
Background: Vascular calcification (VC) and vascular stiffness (VS) significantly increase cardiovascular risks in renal dialysis (RD) patients. Currently, several interventions have been tried to alleviate VC and VS, but they all lack s...
Bibliographical & Catalog Notes
Print issues ceased with 2020.
Also issued online.